Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-02-21 @ 3:14 PM
Study NCT ID:
NCT00658320
Status:
COMPLETED
Last Update Posted:
2013-06-21
First Post:
2008-04-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids
Sponsor:
Novartis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02
Start Date Type:
None
Primary Completion Date:
2010-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-10
First Submit QC Date:
None
Study First Post Date:
2008-04-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-08-10
Results First Submit QC Date:
None
Results First Post Date:
2011-09-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-05-13
Last Update Post Date:
2013-06-21
Last Update Post Date Type:
ESTIMATED